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a b s t r a c t
Obsessive–compulsive disorder (OCD) is a chronic and debilitating condition that is relatively common in
both children and adults, and it is associated with a wide range of functional impairments. Mental health
researchers and practitioners have placed considerable attention on OCD over the past two decades, with the
goal of advancing treatment and understanding its etiology. Until recently, it was unknown to what extent
this disorder was associated with functional impairment. However, recent research shows that the condition
has signiﬁcant social and occupational liabilities. This article discusses etiology, common symptom
presentations (including comorbid and ancillary symptoms), basic OCD subtypes, neuropsychological
functioning, and the relation these have with functional disability in OCD. Recommendations for future
research are also considered.
© 2009 Published by Elsevier Ltd.

Contents
1.
2.

Introduction . . . . . . . . . . . . . . . . . . . . . .
Obsessive–compulsive disorder and functional impairment
2.1.
Etiology . . . . . . . . . . . . . . . . . . . . .
2.1.1.
Genetics . . . . . . . . . . . . . . . .
2.1.2.
Neuroanatomy . . . . . . . . . . . . .
2.1.3.
Neurochemistry . . . . . . . . . . . . .
2.1.4.
Neuropsychology . . . . . . . . . . . .
2.1.5.
Implications of neurobiological ﬁndings for
2.2.
Psychological models . . . . . . . . . . . . . .
2.2.1.
Learning principles . . . . . . . . . . .
2.2.2.
Cognitive model . . . . . . . . . . . .
2.3.
Subtypes of OCD . . . . . . . . . . . . . . . . .
2.3.1.
Contamination . . . . . . . . . . . . .
2.3.2.
Harming . . . . . . . . . . . . . . . .
2.3.3.
Symmetry/ordering . . . . . . . . . . .
2.3.4.
Pure obsessions . . . . . . . . . . . . .
2.3.5.
Hoarding . . . . . . . . . . . . . . . .
2.4.
Stability and change in OCD symptoms . . . . . .
2.5.
Scope of functional impairment . . . . . . . . .
2.5.1.
Sleep disturbance . . . . . . . . . . . .
2.5.2.
Occupational and educational functioning
2.6.
Quality of life . . . . . . . . . . . . . . . . . .
2.6.1.
Healthcare utilization . . . . . . . . . .
2.7.
Comorbidity . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
functional impairment
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .
. . . . . . . . . . .

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

⁎ Corresponding author. Department of Psychology, Fordham University, Bronx, NY 10458, USA. Tel.: +1 718 817 4498.
E-mail address: mckay@fordham.edu (D. McKay).
0272-7358/$ – see front matter © 2009 Published by Elsevier Ltd.
doi:10.1016/j.cpr.2009.09.005

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

79
79
79
79
80
80
80
81
81
81
81
82
82
83
83
83
84
84
84
84
84
84
84
85

Y. Markarian et al. / Clinical Psychology Review 30 (2010) 78–88

3.
Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acknowledgment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1. Introduction
Signiﬁcant progress has occurred over the past two decades in the
understanding of the phenomenology and pathophysiology of obsessive–compulsive disorder (OCD), a chronic and debilitating anxiety
disorder found with relative frequency in both children and adults.
Obsessive–compulsive disorder is more common than previously
believed, affecting between 1% and 3% of the population (Rasmussen
& Eisen, 1994; Torres et al., 2006). Epidemiological studies suggest that
OCD represents the fourth most common mental disorder, following
phobias, substance abuse, and major depression (Karno, Golding,
Sorenson, & Burnam, 1988). Prevalence rates appear to be equal across
genders, with a slight tendency toward a higher prevalence for women
evident in some studies (Antony, Downie, & Swinson, 1998). Crossculturally, the disorder has similar prevalence rates and a consistent
symptom presentation (Weissman, Bland, Canino, & Greewald, 1994).
The World Health Organization (2001) ranked OCD as one of the most
debilitating mental health disorders and estimated that, in 2000, OCD
was among the top 20 causes of illness-related disability for people aged
15 to 44 years. In the great majority of cases, OCD symptoms start in
childhood (Pauls, Alsobrook, Goodman, Rasmussen, & Leckman, 1995);
for instance, in clinical samples, the mean age of onset was 10 years
(Swedo, Rapoport, Leonard, Lenane, & Cheslow, 1989), with earlier age
of onset in males (i.e., prepuberty) than in females (i.e., adolescence)
(Geller, 2006; Tukel et al., 2005). Given these ﬁndings for age of onset
and associated disability, it is clear that OCD contributes to signiﬁcant
functional impairment.
The course of OCD is typically chronic, with an increase of symptoms
often associated with stressful life events (Cromer, Schmidt, & Murphy,
2007). In most cases, the course is continuous, although in some cases it
may be episodic or even deteriorating. Initial onset is often marked by a
gradual increase of symptoms (American Psychiatric Association [APA],
2000; Antony et al., 1998). Further, many writers emphasize chronicity
of OCD, noting that sufferers often undergo setbacks in maintaining
treatment gains and require ongoing attention to managing their
symptoms (i.e., Jenike, Baer, & Minichiello, 1998; McKay, Todaro,
Neziroglu, & Yaryura-Tobias, 1996). Finally, whereas effective treatments have been developed, many sufferers either fail to respond,
respond partially, or relapse shortly after treatment (Abramowitz et al.,
2003; Franklin et al., 2000). Such chronicity has led to the widespread
view that OCD is associated with signiﬁcant functional impairment and
reduced quality of life. The present paper offers an integrative view of
the facets of OCD that lead to functional impairment, including
etiological and comorbid contributions, as well as the basic subtypes
and dimensions of the disorder.
2. Obsessive–compulsive disorder and functional impairment
Obsessive–compulsive disorder is characterized by obsessions
and/or compulsions that lead to signiﬁcant distress and cause severe
impairment in psychosocial functioning (APA, 2000; Leonard, Goldberger, Rapoport, Cheslow, & Swedo, 1990). Obsessions are repetitive,
intrusive, and distressing thoughts, ideas, images, or urges that often
are experienced as meaningless, inappropriate, and irrelevant, and
persist despite efforts to suppress, resist, or ignore them (APA, 2000).
Common obsessions include thoughts about contamination (55%),
inappropriate aggressive (50%) or sexual (32%) thoughts or images,
concern over symmetry or exactness (36%), and somatic fears (34%)
(Abramowitz, Franklin, Schwartz, & Furr, 2003; Rasmussen & Tsuang,
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1986). Compulsions are repetitive, stereotyped behaviors and/or
mental acts that are used to diminish the anxiety and distress
associated with the obsessions (APA, 2000). The most common
compulsions include checking (80%), cleaning or decontamination
rituals (e.g., excessive washing, bathing, or grooming; 46%), and
counting (21%) (Abramowitz et al., 2003; Masi et al., 2005; Rasmussen
& Tsuang, 1986).
Often, obsessions and compulsions are linked by content. For
instance, individuals who have recurrent thoughts about making
mistakes may check their work incessantly, while those who
experience contamination concerns may engage in elaborate hand
washing and bathing routines. Examination of symptoms among OCD
patients along with factor analyses of OCD assessment measures
provide support for dimensions and “subtypes” of OCD in which
obsessions and compulsions load together on the same symptombased factors and clusters (e.g., Leckman, Grice, Boardman, & Zang,
1997; Summerfeldt, Richter, Antony, & Swinson, 1999). Although the
DSM-IV criteria imply that it is possible for a person to experience
compulsions without obsessions (or vice versa), the vast majority of
OCD patients have both obsessions and compulsions (Foa & Kozak,
1995). Indeed, only 2.1% of patients with OCD report predominant
obsessions, 1.7% report predominant compulsions, and more than 95%
reported both obsessions and compulsions on the Yale–Brown
Obsessive Compulsive Symptom Checklist (Foa & Kozak, 1995;
Goodman et al., 1989).
2.1. Etiology
Several lines of genetic, neuroanatomical, neurochemical, and
psychological research point to OCD as a complex neurobehavioral
illness that likely has multiple etiological determinants. What follows
is a brief review of each domain.
2.1.1. Genetics
Twin and family study ﬁndings suggest that genetic factors are
involved in the transmission and expression of OCD (Hanna, Himle,
Curtis, & Gillespie, 2005; Jonnal, Gardner, Prescott, & Kendler, 2000;
Karno et al., 1988; Nestadt et al., 2000; Pauls et al., 1995). Twin studies
report higher concordance rates for OCD in monozygotic (80%–87%)
than dizygotic twins (Carey & Gottesman, 1981) and variable
heritability rates ranging from 26% to 65% (Eley et al., 2003; Hudziak
et al., 2004). Family studies reveal that, generally, risk of developing
OCD is greater in ﬁrst-degree relatives of individuals with OCD than
among the general population (Nestadt et al., 2000; Pauls et al., 1995).
For example, a meta-analysis of controlled family studies based on
adults with OCD showed an aggregate risk of 8.3% in ﬁrst-degree
relatives of participants with OCD and 2% in ﬁrst-degree relatives of
control participants (Hettema, Neale, & Kendler, 2001). In other
words, a person with OCD is about 4 times more likely to have another
family member with OCD than is a person without OCD. Moreover, it
appears that childhood onset OCD has a stronger genetic contribution
than does later onset OCD, with studies showing that OCD is more
common in relatives of those with child onset (11%–23%) compared
with adult onset (8.3%) (do Rosario-Campos et al., 2005; Hanna et al.,
2005; Nestadt et al., 2000; Pauls et al., 1995).
Although twin and family studies point to a genetic component of
OCD, the speciﬁc genes and inheritance mechanisms involved are less
clear. Theories of the genetic factors involved in the pathogenesis of the
disorder have varied from a multifactorial conceptualization (Lipsman,
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Neimat, & Lozano, 2007), to speciﬁc genes, such as the chromosome
9p24 (Willour et al., 2004). To date, the most consistent ﬁndings have
centered on the sapap3 and serotonin transporter genes (reviewed in
Abramowitz, Taylor, & McKay, 2009). Still other studies have considered
candidate genes affecting serotonin, dopamine, and glutamate neurotransmissions (Hemmings & Stein, 2006; for a review of genetic studies
of OCD, see Arnold & Richter, 2007). Given this, it appears that there are
genetic features of the disorder, but that no one set of genes has been
isolated that explain the disorder. This may be due, in part, to the
considerable heterogeneity of the disorder noted earlier. It is important
to note that most of the studies reviewed above do not control for shared
environment and common learning histories that might confer greater
familial transmission of the disorder (Jang & Shikishima, 2009, for a
methodological discussion of identifying unique variance associated
with environmental and genetic factors).
2.1.2. Neuroanatomy
There is increasing evidence for involvement of neurobiological
factors in the etiology of OCD. The precise neurobiological mechanisms underlying OCD symptoms remain poorly understood (Maia,
Cooney, & Peterson, 2008); however, relatively recent neurobiological
studies on OCD patients compared with controls show hyperactivity
during rest in a cortico-basal-thalamo-cortical loop that includes the
orbitofrontal cortex (OFC), the anterior cingulate cortex (ACC), and
the head of the caudate nucleus (Maia et al., 2008; Maltby, Tolin,
Worhunsky, O'Keefe, & Kiehl, 2005). As compared with those who do
not have OCD, individuals with the disorder evidence comparatively
more activity in the orbitofrontal cortex (Saxena, Bota, & Brody,
2001). Thus, frontal–striatal circuitry that is ‘wired’ for atypical
conscious awareness may explain the repetitive nature of OCD-related
thoughts and rituals. Further, a meta-analysis of OCD functional
neuroimaging studies found consistent differences between patients
with OCD and healthy controls — speciﬁcally, in the orbital–frontal
gyrus (within the frontal lobe) and the head of the caudate nucleus
(part of the striatum; Whiteside, Port, & Abramowitz, 2004). There is
some evidence to suggest differential pathology dependent upon
either age of onset or current age, as the thalamus is commonly
implicated in children (Busatto et al., 2001; Friedlander & Desrocher,
2006).
2.1.3. Neurochemistry
The serotonergic and dopaminergic neurotransmitter systems are
among several that have been associated with the pathogenesis of
OCD. Support for the serotonin hypothesis (i.e., implication of the
serotonergic system in OCD presentation) has been drawn mainly
from clinical trials demonstrating the efﬁcacy of selective serotonin
reuptake inhibitors (SSRIs) in the treatment of both adult and
pediatric OCD (March et al., 1998; Insel, 1990; Pediatric OCD
Treatment Study [POTS], 2004; Rapoport, Leonard, Swedo, & Lenane,
1993).
The mechanism proposed is that individuals with OCD have
excessive baseline activity of excitatory glutamatergic neurons in the
orbitofrontal cortex; serotonin inhibits these neurons, resulting in an
increased release of serotonin in the orbitofrontal cortex, thus leading
to a decline in OCD symptoms (Husted, Shapira, & Goodman, 2005).
Further support for the serotonin hypothesis was derived from studies
investigating the function of speciﬁc serotonin receptors (Adams
et al., 2005; Hollander et al., 1992; Zohar, Mueller, Insel, ZoharKadouch, & Murphy, 1987). For example, the administration of certain
serotonin agonists (e.g., meta-chlorophenylpiperazine) led to an
exacerbation of OCD symptoms (Stein, Van Heerden, Wessels et al.,
1999).
A recent review of pharmacological treatment of OCD indicates
that SSRIs are associated with a meaningful clinical response in
approximately 40–60% of patients and generally produce only mild
side effects (Math & Janardhan-Reddy, 2007). Patients whose

symptoms do not reduce after an initial SSRI trial may show
improvement on a second SSRI trial (Math & Janardhan-Reddy,
2007). Individuals with OCD who experience high levels of side effects
from SSRIs or who are refractory to SSRI treatment may require
additional pharmacotherapeutic or behavioral interventions (Simpson et al., 2008). Tricyclic antidepressants (TCAs), such as clomipramine and imipramine, are effective in the treatment of OCD symptoms
(Denys, 2006), with clomipramine having good efﬁcacy relative to
placebo across a number of studies (Geller et al., 2003; Math &
Janardhan-Reddy, 2007); however, the frequency of adverse side
effects is higher for TCAs than for SSRIs. Thus, SSRIs remain the ﬁrstline pharmacotherapeutic treatment for OCD symptoms.
Although not entirely consistent, studies of peripheral markers,
pharmacologic challenge, and treatment response imply that dopamine excess may also be involved in the etiology of OCD (Creese &
Iversen, 1974; Denys, Zohar, & Westenberg, 2004; Eilam, Golani, &
Szechtman, 1989; van der Wee et al., 2004). For instance, Neale and
Oltmanns (1988) found that, following levodopa treatment (i.e.,
which increases dopamine reserves) of tardive dyskinesia, patients
exhibited OCD symptoms. Moreover, higher levels of dopamine
transporter density were found in the left caudate and left putamen
of patients with OCD versus control patients. Additionally, studies
have supported antipsychotic augmentation in SSRI non-responders
and incomplete responders (Bloch et al., 2006). For example,
McDougle et al. (1994) found that the addition of haloperidol (an
antipsychotic medication that blocks dopamine D2 receptors) led to
augmentation of SSRI response, particularly in patients with comorbid
tics. Other controlled adult studies (McDougle, Epperson, Pelton,
Wasylink, & Price, 2000; Skapinakis, Papatheodorou, & Mavreas,
2007) and several adolescent case series (e.g., Fitzgerald, Stewart,
Tawile, & Rosenberg, 1999; Storch, Lehmkuhl, Geffken, Touchton, &
Murphy, 2008; Thomsen, 2004) have supported atypical antipsychotic augmentation. In treatment refractory cases, benzodiazepines may
also be used; however, individuals should be aware of the increased
possibility of dependence, side effects, and interactions with other
medications and substances (Bandelow, 2008; Denys, 2006).
There are also limitations of pharmacotherapy as a therapeutic
strategy for OCD. First, as many as 40% to 50% of OCD patients treated
with SSRIs fail to respond (Bandelow, 2008; Denys, 2006). In addition,
several pharmacotherapy interventions have side effect proﬁles and
several require extensive monitoring by medical professionals (e.g.,
TCAs and benzodiazepines). Further, SSRIs can require 6 to 8 weeks
before reaching optimal efﬁcacy. This information is particularly
important for patients since side effects such as restlessness,
jitteriness, an increase in anxiety symptoms, or insomnia which
lasts through the ﬁrst days or weeks of treatment may hamper
treatment compliance (Murphy, Segarra, Storch, & Goodman, 2008).
Finally, discontinuation of pharmacological treatment is clearly
associated with symptomatic relapse, irrespective of treatment
duration, and a substantial proportion of OCD patients require lifelong
medication use (Math & Janardhan-Reddy, 2007). This is likely
because patients have not learned how to directly cope with their
obsessive thoughts and compulsive avoidance and rituals. While there
are a number of efﬁcacious pharmacologic strategies, most of these
approaches involve potentially serious and difﬁcult to tolerate
adverse side effects (i.e., TCAs, typical neuroleptic augmentation) or
provide relief while leaving sufferers with residual clinically-significant symptoms (i.e., SSRIs).
2.1.4. Neuropsychology
Neuropsychological studies of individuals with OCD show a
consistent pattern of deﬁcits in fronto-striatal executive functions,
particularly in utilization of organization strategies, as well as some
limited evidence for memory impairments (Greisberg & McKay,
2003). The pattern of deﬁcits in executive skills is demonstrated in
multiple studies using a variety of executive-functioning tasks that
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show impairments in the ability to shift set, organize, plan, and
quickly solve problems (Gambini, Abbruzzese, & Scarone, 1993;
Mataix-Cols, Jungque, & Sanchez-Turet, 1999; Veale, Sahakian, Owen,
& Marks, 1996).
Memory functions in individuals with OCD, however, are more
variable. Some have suggested that, given OCD-related reports of
extensive doubt for actions, or sense of incompleteness in ritual
behavior (such as doubting for actions, as in checking the stove when
turning it off), OCD is associated with memory dysfunction. While this
is a plausible consideration, accumulated data on memory functioning,
separate from other neuropsychological areas of assessment, do not
suggest poorer memory than that for other anxiety disorders (Savage,
1998). In some instances, memory performance is even superior in
individuals with OCD relative to controls, and that the distinguishing
factor was memory conﬁdence (i.e., Radomsky, Gilchrist, & Dussault,
2006). These memory ﬁndings produce a complex clinical picture
whereby individuals with OCD likely have at least normal memory
functioning but poorer trust in their memory for speciﬁc threatrelevant events. The marked deﬁcits in executive functioning that
occur in the frontal–striatal circuit loop as well as lack of trust in
memory abilities may help to explain global cognitive processing
impairment in OCD. This, in turn, can lead to issues with decisionmaking, thus impacting both social and occupational functioning.
However, an additional question regarding neuropsychological
functioning in OCD involves the manner in which memories are
organized. For all the neuropsychological investigations conducted for
OCD, the greatest consistency in research ﬁndings has come from the
interplay between organization strategy and memory encoding
(Greisberg & McKay, 2003). Speciﬁcally, using a scoring system that
ranks efﬁciency of organizational approach in completing the designs
on the Rey Complex Figure Test (RCFT; Rey, 1941), individuals with
OCD consistently score lower than other patient groups (Savage et al.,
1999). Organizational strategy on the RCFT is critical for better
performance, and thus highly salient when considering working
memory functioning in individuals with OCD (Greisberg & McKay,
2003). Thus, while more information is clearly needed in this area,
OCD-related memory impairments are likely related to executive
planning and organization difﬁculties, rather than direct impairments
to learning and memory systems.
2.1.5. Implications of neurobiological ﬁndings for functional impairment
Each of the above reviewed areas point to (a) complex systems of
impairment at the genetic, neurochemical, neurobiological, and
neuropsychological levels; and (b) challenges in remedying these
impairments. To take one example, psychopharmacological approaches
are designed to target a subset of neurotransmitters and their associated
brain areas. However, the degree that each neurotransmitter must be
targeted, and in what sequence, in order to properly alleviate symptoms,
is complicated by the heterogeneity of symptom expression. Without a
clear unifying underlying mechanism for the condition (Taylor, McKay,
& Abramowitz, 2005), the search for a more uniformly effective
neurobiological treatment strategy will remain limited.
2.2. Psychological models
2.2.1. Learning principles
Development of OCD appears to be inﬂuenced by learning principles.
Mowrer's (1960) two-factor learning model has been used as an
explanation for the acquisition and maintenance of OCD symptoms.
According to this model, OCD 1) develops through classical conditioning, such that a previously neutral stimulus, through pairing with an
aversive stimulus, comes to elicit a conditioned fear response; and 2) is
maintained through operant conditioning, as the initiation of compulsions or rituals serves to neutralize obsessions and the subsequent
reduction in anxiety serves as a negative reinforcer that maintains the
compulsive behaviors. The operant conditioning component of this
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model has found strong empirical support (Rachman & Hodgson, 1980).
Involvement of classical conditioning, on the other hand, remains
questionable: namely, (a) individuals with OCD do not generally report
a speciﬁc traumatic experience linked with the development of their
fears; (b) the onset of the disorder tends to be rather pervasive and
gradual (Abramowitz, Taylor, & McKay, 2007); and (c) individuals'
symptoms often change over time, a pattern that cannot widely be
explained by new traumatic events or generalization of the fear from a
particular initial traumatic event. Whereas the underlying classical
conditioning basis of this model may not adequately explain symptoms
of the disorder (Taylor, Abramowitz, & McKay, 2007), it has served as the
basis for exposure with response prevention, which remains the
dominant approach to treatment (Abramowitz, Taylor, & McKay, 2005).
Moreover, recent research indicates that symptoms of OCD may be
motivated by factors other than fear, such as feelings of incompleteness or “not just right experiences” (NJREs) (e.g., Leckman et al., 1997;
Coles, Heimberg, Frost, & Steketee, 2005), which are frequently
reported among clients with OCD. In fact, it has been reported that as
symptom severity increases, so too do the presence and severity of
NJREs. Not just right experiences are phenomenological in nature,
whereby the sufferer complains that something is not right, or that
actions must be repeated until they feel ‘right.’ In some individuals
with OCD, these symptoms can be severely disabling. For example,
one of the authors (DM) worked with a client for whom the NJREs
were sufﬁciently severe that she required up to an extra three hours
per day in repeating and completing actions until they ‘felt right.’
These symptoms generally disappeared when another person was
present, making exposure exercises difﬁcult to develop and execute
since these procedures could not be completed in the presence of a
therapist.
The experimental literature suggests that NJREs are common
among individuals without OCD as well, and that these sensations can
be provoked in the lab (Coles et al., 2005). When induced
experimentally, such experiences can cause distress and repeated
urges to correct the phenomena. Correspondingly, given the highly
aversive nature of NJREs, individuals generally feel a strong urge to
complete the action until it feels ‘right,’ even if it means neglecting
other pressing activities.
2.2.2. Cognitive model
The cognitive model builds on the premise that OCD is the result of
a set of reactions that stem from, and intensify, otherwise normal
intrusive thoughts (Rachman, 1997; Salkovskis, 1985, 1989). The
theory proposes that mental intrusions are normal experiences that
individuals have periodically and that obsessions experienced by
people with OCD are not qualitatively different from the intrusive
thoughts that occur in people who do not suffer from the disorder.
However, unlike those without the disorder, people with OCD
appraise such thoughts as highly signiﬁcant and threatening and
view themselves as personally responsible for whatever harm may
result. Common dysfunctional beliefs or thinking errors include blame
or inﬂated responsibility for outcome (i.e., the belief that one has
special powers to cause, and/or the duty to prevent, negative
outcomes), thought–action fusion (i.e., the belief that thoughts can
inﬂuence events in the world), need to control thoughts (i.e., the
belief that complete control over one's own thoughts is necessary and
possible), overestimation of threat (i.e., the belief that negative and
catastrophic events are extremely likely), and intolerance for
uncertainty (i.e., the belief that it is possible to completely prevent
negative outcomes from occurring) (Obsessive Compulsive Cognitions Working Group [OCCWG], 1997).
Whereas the cognitive model has grown to dominate the contemporary conceptualization of OCD, there are several important caveats to
its adequacy in describing the disorder. First, recent research suggests
that the emphasis on inﬂated responsibility may not describe signiﬁcant
numbers of OCD sufferers. For example, using data from the OCCWG
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scale development trial for the development of a major scale for
assessing cognitive distortions associated with OCD, approximately half
of those with OCD did not endorse theoretically associated distortions
(Taylor et al., 2006). Further research with the same dataset showed that
while there is one cognitive subtype associated with responsibility, there
are separate subtypes of sufferers primarily characterized by perfectionism and by excessive concerns regarding the importance of thoughts
(Haslam, Williams, Kyrios, McKay, & Taylor, 2005).
Finally, there also exists substantial numbers of sufferers whose
symptoms are characterized by overvalued ideation (Kozak & Foa,
1994). Overvalued ideas in this context involve an experience whereby
the individual with OCD feels not only compelled to complete the
compulsions that arise from the obsession, but also frequently views the
obsession as reasonable. While not necessarily delusional, this problem
creates difﬁculties in conceptualizing the disorder as based on primary
cognitive errors that can be challenged, and may serve as a barrier to
behavioral interventions such as exposure with response prevention.
Overvalued ideas are a poor prognostic indicator in the treatment of
OCD. Central to contemporary treatment is that individuals have frank
recognition that the link between obsessions and compulsions is illusory
(McKay & McKiernan, 2005), a process that breaks down when
overvalued ideas are present. The presence of overvalued ideas
represents a signiﬁcant barrier to treatment, since the client does not
readily recognize the illusory link between obsessions and compulsions.
A fundamental feature of CBT for OCD involves exposure with response
prevention (ERP) (Abramowitz et al., 2005). However, individuals with
overvalued ideas express great reluctance to engage in these exercises,
or refuse altogether. As yet, there are no accepted modiﬁcations to
treatment to address this problem in OCD, although motivational
interviewing (Miller & Rollnick, 2002) has been suggested a potentially
promising approach (Merlo et al., in press; Tolin & Maltby, 2007).
Whereas overvalued ideas involve a pathologically extreme belief in
the realistic aspect of thoughts, and the necessity of corresponding
compulsions, scrupulosity is rooted more closely in cultural or religious
beliefs that are held in an extreme manner. This connection is most
apparent in individuals who present for treatment due to religious or
cultural practice obsessions and compulsions. There is a wide range of
ways that these concerns may be manifested including precision of
religious practices (i.e., perfect ritualized prayer), excessive concerns
over blasphemous thoughts, doubts that a sin has been committed, or
concerns over offending tribal elders even when no opportunity for such
offenses have occurred. Symptoms of scrupulosity are particularly
troubling and the barrier to treatment is much the same as for
overvalued ideas, in that most clients express extreme reluctance in
practicing exercises that may violate religious or cultural beliefs as the
beliefs are viewed as rational. That is, scrupulosity may be viewed as an
ampliﬁcation of an existing religious or cultural belief, and not
necessarily excessive. For example, hand washing is prominent in
many religious practices. If someone has contamination fears related to
religious practices, such as concerns over contact with non-kosher
meats, the associated hand washing could become a problem of
scrupulosity. This would stand in contrast to the contamination fear
sufferer who washes after contact with doorknobs not out of religious
concerns but because of fears that others left behind germs. Abramowitz
(2008) details modiﬁcations to CBT to engage individuals with
scrupulosity in practicing ERP-based treatment, which is heavily reliant
on a combination of motivational interviewing and illustrations of ways
the rules that have developed around the OCD symptoms have been
violated routinely by the client. Problems associated with scrupulosity
represent another important barrier to treatment implementation and
outcome (McKay, Taylor, & Abramowitz, 2010) and in turn, a signiﬁcant
contributor to difﬁculties in everyday functioning.
Subsequent to dysfunctional thinking, people with OCD experience
an increase in distress and negative affect that leads to attempts to
control or suppress the disturbing thoughts and efforts to neutralize any
possible harmful consequences. Thus, compulsions and avoidance

behaviors are maintained because they: (a) are followed by a shortterm reduction in anxiety (negative reinforcement); (b) prevent a
natural decrease in anxiety; (c) are reminders of obsessional thoughts
thus further triggering such cognitions; and (d) are further reinforced by
being attributed the ability to prevent feared consequences from
occurring. In short, compulsions momentarily reduce the distress and
discomfort associated with the misinterpretation of normal mental
intrusions, but paradoxically increase the subsequent occurrence of
intrusions and further strengthen negative interpretations (Rachman,
1997; Salkovskis, 1999). The intrusions escalate into distressing and
persistent clinical obsessions maintained by compulsive rituals that
prevent the rectiﬁcation of mistaken appraisal (Abramowitz et al., 2007).
Different aspects of cognitive-behavioral theory for OCD have been
empirically investigated. For instance, studies found that intrusive
thoughts are indistinguishable in terms of form and content from
clinical obsessions and occur in about 80% of the general population, but
patients with OCD experience more intense, longer and more frequent
mental intrusions than patients without OCD and they are less able to
ignore or disregard them (Rachman & de Silva, 1978; Salkovskis &
Harrison, 1984). Several studies have demonstrated that catastrophic
appraisal of intrusive thoughts and perceptions of personal responsibility were correlated with measures of OCD symptom severity and that
patients with OCD reported higher responsibility for outcomes related
to their thoughts than normal controls (e.g., Clark & Purdon, 1993;
OCCWG, 2003; Smári & Hólmstein, 2001). Moreover, experimental
studies of the effects of responsibility appraisal showed that experimentally induced thought–action fusion beliefs in naïve participants led
to an exacerbation of distressing thoughts and ritualistic behavior
similar to OCD symptoms (Rassin, Merckelbach, Muris, & Spaan, 1999).
On the same lines, other experimental studies demonstrated that efforts
to suppress unwanted thoughts led to an increase in the frequency of
such thoughts (Abramowitz, Tolin, & Street, 2001) and that repetitive
checking led to an increase in doubt and uncertainty (van den Hout &
Kindt, 2003). These studies provide support for the hypotheses that OCD
is maintained by rituals and that attempts to suppress obsessional
thoughts further trigger these cognitions and subsequent associated
compulsions.
2.3. Subtypes of OCD
Although the DSM-IV-TR speciﬁes symptom parameters (i.e.,
obsessions, compulsions) there is less speciﬁcity regarding the
content of symptoms that are associated with OCD. Recently, there
has been considerable focus on distinctions among the heterogeneous
symptom presentation that characterizes OCD. OCD is a symptomatically diverse condition, in which there are a wide range of differing
types of obsessions and compulsions, with varying degrees of
functional impairment and responsiveness to treatment. For these
reasons, many researchers now agree that particular kinds of
obsessions and compulsions tend to co-occur to form ﬁve main
empirically-derived subtypes of OCD: (1) Contamination (contamination obsessions with cleaning/washing compulsions); (2) Harming
(doubting obsessions with checking compulsions); (3) Symmetry/
ordering (symmetry obsessions with ordering, arranging, and counting compulsions); (4) Pure Obsessions (often of a sexual, religious,
aggressive or somatic nature, without overt compulsions); and (5)
Hoarding (hoarding obsessions and collecting compulsions). Among
these, individuals with either cleaning or contamination rituals are
among the most common within OCD patient samples, accounting for
75% of OCD patients (Ball, Baer, & Otto, 1996).
2.3.1. Contamination
The contamination subtype of OCD is characterized by overwhelming fear and intrusive thoughts of either becoming contaminated or accidentally spreading contamination in some way. There is
evidence from the cognitive literature that individuals who suffer
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from the Contamination subtype may possess excessive memory
capabilities for threat-associated cues and enhanced attention toward
contamination-associated stimuli (Foa, Ilai, McCarthy, Shoyer, &
Murdock, 1993; Tata, Leibowitz, Prunty, Cameron, & Pickering,
1996). The object of contamination can vary, and involves common
sources (e.g., germs, poisons, etc.) or unlikely sources (e.g., feeling
‘dirty’ in response to particular thoughts). Fears of contamination are
often rooted in implausible beliefs and generalize over time,
sometimes leading benign substances to be viewed as being
contaminated due to similarity in appearance to actual contagions
(e.g., chocolate fudge in the shape of dog feces), or to magical beliefs
that a contagion will last forever (e.g., refusal to touch an object
belonging to a person with hepatitis) (Rozin, Millman, & Nemeroff,
1986). This connection to implausible beliefs has led to research
suggesting that disgust reactions may underlay the anxiety connected
with contamination concerns leading to avoidance of potentially
contaminating/contaminated stimuli (McKay & Moretz, 2009; Moretz
& McKay, 2008; Olatunji & McKay, 2007). Problematic in treatment for
many individuals with contamination fears is that disgust appears to
habituate more slowly than anxiety when treatment involving
exposure is applied (McKay, 2006). Given the dominant role of
disgust in contamination fear, and comparatively limited research on
this emotional state, problems associated with contamination fear
may be more difﬁcult to treat than previously considered.
Individuals with contamination obsessions will typically engage in
excessive washing or cleaning to either reduce the feeling of
contamination, or to avoid potential danger of contamination (McKay
& Robbins, 2008). Such cleaning/washing compulsions are repetitive,
ritualistic, time-consuming behaviors that the person feels compelled to
perform to reduce distress caused by the obsessive thoughts of
contamination, or mental ‘dirtiness,’ disgust, and shame (Sookman,
Abramowitz, Calamari, Wilhem, & McKay, 2005).
2.3.2. Harming
Typically, the harming subtype is characterized by distressing
doubting obsessions with checking compulsions. While prevalence
rate of these obsessions is not clearly described in the research literature,
it is a commonly reported primary symptom, and constitutes a subtype
based on prior cluster and factor analytic research (McKay et al., 2004).
Salkovskis describes maladaptive assumptions in OCD which are
triggered by enduring beliefs related to the theme of responsibility.
Such beliefs are rooted in critical events early in childhood and
include a general understanding that one carries an excessive burden
of responsibility for preventing threat. Further, by not taking direct
action to prevent harm, one becomes essentially responsible for any
harm that is produced (Salkovskis, 1985). This overwhelming sense of
responsibility is viewed by Salkovskis as the core of all obsessional
thinking in OCD, and speciﬁcally the increased sense of responsibility
towards protecting from harm. Indeed, responsibility beliefs signiﬁcantly predict harm obsessions but no other symptoms of OCD (Clark,
2004). Additionally, recent reﬁnements to the inﬂated responsibility
perspective include over-importance and control over thoughts
(OCCWG, 2003) and the belief that individuals possess the power to
cause, or prevent negative, even catastrophic events and considerable
harm to others through a cognitive process referred to as ‘thought–
action fusion’ (e.g., having the thought is like performing the action)
(Shafran, Thordarson, & Rachman, 1996). This inﬂated sense of
responsibility leads to compulsive checking of those items for which
the individual feels personally responsible for (e.g., sharp objects they
own), as opposed to undifferentiated harmful objects (e.g., knives
belonging to others). Further, individuals with harming obsessions
become concerned about the content of their thoughts, assigning
signiﬁcance to thoughts that might be deemed unacceptable or
potentially harmful to others. Individuals may spend hours each day
physically checking and re-checking not only the security of objects in
their environments (e.g., a locked door, an unplugged appliance), but
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may also engage in countless ‘mental’ checks to review whether their
enacted checks were performed correctly, which may interfere with
their ability to concentrate and focus on other tasks.
The harming subtype of OCD is perhaps the most heterogeneous
(McKay et al., 2004) and has shown considerable symptom overlap in
factor analytic studies with other symptom clusters of OCD. Typically,
doubting obsessions will lead individuals to engage in checking
compulsions to conﬁrm a lack of harm. Due to symptom overlap with
other obsessive symptoms (e.g., contamination or aggression), some
individuals will compulsively check not only to reduce harm, but to
neutralize contamination or aggressive obsessions (e.g., constantly
checking the rear-view mirror for injured persons). Alternatively, one
may wash repeatedly not out of concern of becoming contaminated
but out of concern that they will carry infection to others. These
manifestations are but a few ways that harming obsessions may
differentiate, and yet appear topographically similar to other major
symptom subtypes thus challenging the current models of OCD in
their ability to adequately account for the full range of potential
symptoms (McKay et al., 2004; Taylor, McKay, & Abramowitz, 2005).
Finally, as harming is primarily associated with obsessions, with less
prominent overt compulsions, individuals with this subtype are more
likely to experience depression (Ricciardi & McNally, 1995), which is a
signiﬁcant liability for behavioral treatment of OCD (Steketee &
Shapiro, 1995).
2.3.3. Symmetry/ordering
Symmetry obsessions have been found in 10–43% of OCD samples,
and compulsions concerning symmetry/precision have been reported in
6–52% of individuals with OCD (Rasmussen & Eisen, 1992; Foa et al.,
1995; Okasha, Saad, Khalil, Dawla, & Yehia, 1994), making the
symmetry/ordering subtype the second most commonly reported.
This subtype of OCD is characterized by compulsions involving
extensive and ritualistic repeating, counting, symmetry, ordering and
arranging, as well as obsessions related to exactness/perfectionism and
‘obsessional slowness.’
A differentiating feature of this subtype is that, in contrast to the
overwhelming fear and distress associated with obsessions of producing/preventing danger in contamination and harming subtypes,
individuals with symmetry/ordering obsessions perform compulsive
behaviors in order to reduce feelings of dissatisfaction, discomfort, or
inadequacy, rather than anxiety or distress (McKay et al., 2004). Further,
the underlying motivational factor for compulsions of symmetry and
ordering seems to be markedly different from that of other forms of OCD
in its attempt to resolve a sense of incompleteness rather than a fear of
harm or shame (McKay et al., 2004).
2.3.4. Pure obsessions
Approximately 20–25% of OCD patients report distressing obsessions
without overt compulsive behavioral rituals (Abramowitz, McKay, &
Taylor, 2008; McKay et al., 2004). The pure obsessions subtype of OCD is
characterized by the presence of obsessions in the absence of traditional
anxiety-reducing compulsive behavior. Such obsessions may be of a
religious/blasphemous, violent/aggressive, or sexual nature, and although these obsessions may co-occur with compulsions in other cases,
for individuals with the pure obsessions subtype, they are not linked
with any overt behavioral compulsions (Abramowitz et al., 2008).
However, recent conceptualizations suggest that pure obsessions have
distinct and unique compulsions such as mental rituals that resemble
overt ones (Clark & Guyitt, 2008). Individuals with pure obsessions may
experience their obsessions as either involuntary intrusive thoughts,
impulses, or images (e.g., spontaneous and unacceptable aggressive
thoughts) or reactive thoughts (e.g., cognitive rituals, repeating prayers)
which are in response to external stimuli and are connected with a fear
concerning harm, contamination, or perfection (Sookman et al., 2005).
In either case, the cognitive model suggests that these intrusive
thoughts are appraised as important by their mere occurrence, and
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result in negative affect by their aversive quality (Taylor, Abramowitz,
McKay, & Cuttler, in press).
2.3.5. Hoarding
One of the most disabling forms of OCD is hoarding, which is
deﬁned as the compulsive acquisition of items that often appear
worthless to others (e.g., rotten food, trash, nail clippings), and
associated difﬁculty discarding such items. Prevalence of hoarding
symptoms among OCD patients has been estimated to range from 18–
42% (Sookman et al., 2005). Individuals with hoarding symptoms
report greater anxiety and depression, poorer insight, and more
overvalued ideas (e.g., overemphasized and idealized beliefs which
become congruent with self-identify to the point of creating rigidity
and resistance to treatment) than individuals with other subtypes of
OCD (McKay et al., 2004). Cognitively, these patients possess
dysfunctional beliefs about the value of possessions and develop
excessive emotional attachment to the hoarded items. In addition,
these individuals develop associated symptoms such as obsessional
fear of losing possessions they believe may be eventually necessary;
perfectionism; intolerance of uncertainty; doubt (and overimportance) about memory; difﬁculty making decisions; procrastination;
and behavioral avoidance (McKay et al., 2004; Taylor et al., 2007).
Hoarding is so substantially unique that recent literature has called
into question the appropriateness of its inclusion as a part of OCD
(Petrusa et al., 2008).
2.4. Stability and change in OCD symptoms
Although OCD symptom presentation is generally similar across
ages, there are some differences in pediatric and adult expression. For
instance, some authors suggest that harm obsessions and hoarding
compulsions are less frequent in adults than among children and
adolescents, while sexual obsessions are thought to be more common
in adults (e.g., Geller et al., 2001). At the individual level, symptoms
often change over time and many individuals with childhood onset
experience a wide range of symptoms by the time they reach
adulthood (Rettew, Swedo, Leonard, Lenane, & Rapoport, 1992). As
opposed to adults, children with OCD often have limited insight into
their condition and may be less likely to recognize that their
obsessions and compulsions are excessive or bizarre (Geffken et al.,
2006). Storch, Milsom et al. (2008) investigated the relation between
level of insight and clinical characteristics among 78 children and
adolescents with OCD. They found that 45% of their sample had
limited insight into their symptoms and experienced higher levels of
OCD-related impairment. Nevertheless, independent of the level of
insight, both children and adults may feel ashamed and embarrassed
by their fears and ritualistic behaviors, so they often hide their
symptoms, making early detection and treatment difﬁcult.
2.5. Scope of functional impairment
In light of the review thus far, and the extent of potential
complicating factors that may interfere with treatment, as well as
the wide variety of symptoms and commonly associated comorbid
presentations, there are many ways in which individuals with OCD
can suffer signiﬁcant functional impairments from the condition. At
this point, it appears that OCD is (a) heterogeneous in symptom
presentation; (b) commonly comorbid with other psychiatric disorders; and (c) has several potentially complicating additional
presenting characteristics (i.e., overvalued ideas; scrupulosity) that
limit direct therapeutic intervention. Collectively, these features lead
to impairment in a number of speciﬁc areas as follows.
2.5.1. Sleep disturbance
Insomnia is a problem evident in a wide range of psychiatric
problems. Recent reviews suggest that treating insomnia alleviates

primary psychiatric disturbance (Smith, Huang, & Manber, 2005). In a
review by Smith, Huang, & Manber (2005), there were few studies
examining sleep in individuals with OCD. However, the authors
reported that individuals with subjective complaints about their
symptoms had poorer sleep. While the literature is sparse on the role
of sleep disturbance in OCD, it is evident that insomnia is associated with
greater psychopathology in a wide range of psychiatric conditions
(Manber & Harvey, 2005). Among children, Storch, Murphy et al.,
(2008) found that 92% (N = 66) of children with OCD experienced at
least one sleep problem, with 27.3% reporting ﬁve or more. Sleep
problems were positively associated with OCD symptom severity, childrated anxiety, and parent-proxy ratings of internalizing problems;
following CBT, total and several speciﬁc SRPs (sleep related problems)
were reduced.
2.5.2. Occupational and educational functioning
The research on occupational functioning is limited in OCD. On the
one hand, some have found that the incidence of subclinical
obsessive–compulsive attributes serves an adaptive function and
may be particularly associated with some professional ﬁelds (Akiskal,
Savino, & Akiskal, 2005). In a large (n = 409) study of outpatients,
Yaryura-Tobias et al. (2000) found that symptom severity in OCD was
negatively associated with occupational functioning. Common problems included loss of work, reduction to part-time status, or work in
occupations unrelated to professional training (i.e., non-professional
work when trained for professional career). Whereas the data are
limited on abridged education in adults with OCD, the emerging
literature on childhood OCD suggests that academic functioning is
negatively associated with symptoms as well (Ledley & Pasupuleti,
2007).
2.6. Quality of life
Recently, in one of the most comprehensive assessments of the
relation between symptoms and quality of life, Huppert et al. (2009)
showed that individuals with OCD had signiﬁcantly lower quality of
life compared to individuals whose symptoms had remitted. Further,
there was pervasive functional impairment, including work, social
and family life. Finally, in additional support for the chronic impact of
the disorder, individuals with a prior history of OCD, but few acute
symptoms at the time of the study, had poorer quality of life and
overall functioning than healthy controls. These ﬁndings are
consistent with other research showing a direct negative relationship
between symptom severity and quality of life in individuals with OCD
(i.e., Eisen et al., 2006; Lack et al., 2009). One study found that the
only group with a reported lower level of quality of life than
individuals with OCD was those with schizophrenia (Bobes et al.,
2001).
2.6.1. Healthcare utilization
Individuals with anxiety disorders in general have signiﬁcantly
higher rates of healthcare utilization than other psychiatric groups
and non-psychiatric patients (Kessler et al., 1994; Levy, Maselko,
Bauer, Richman, & Kubzansky, 2007). One possibility identiﬁed is the
higher level of additional medical illness that aggregate in individuals
with anxiety disorders (Levy et al., 2007) suggesting that the stress of
having an anxiety disorder has physical health consequences.
Interestingly, the physical health picture for individuals with OCD
may be better than for other psychiatric disorders. While the study by
Bobes et al. (2001) cited above noted very severe subjective quality of
life, the group with OCD reported fewer physical health concerns than
other patient groups, which included individuals with schizophrenia,
substance abuse, and major depression. However, in light of the
heterogeneity of OCD, it is not clear that this applies to the full range of
individuals with the disorder, or how individuals with OCD compare
to those with other anxiety disorders.
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2.7. Comorbidity
Epidemiologic surveys suggest that, among individuals with OCD,
50% or more have at least one other psychological disorder, most
commonly a comorbid anxiety disorder (e.g., social phobia), or a
unipolar mood disorder (e.g., major depressive disorder) (Steketee &
Barlow, 2002; Torres et al., 2006). Over a quarter of individuals with
OCD present with comorbid alcohol abuse/dependence (Mancebo,
Grant, Pinto, Eisen, & Rasmussen, 2009). OCD is also frequently
comorbid with personality disorders. For example, Denys, Tenney, van
Megen, de Geus, & Westenberg (2004) found that 20.7% of an OCD
sample of 420 individuals had a personality disorder in the anxious
(cluster C) cluster, 9.7% had a personality disorder in the emotionally
expressive (cluster B) cluster, and 1.4% had a personality disorder in
the bizarre/eccentric (cluster A) cluster (Denys, Tenney, van Megen,
de Geus, & Westenberg, 2004). Comorbid obsessive–compulsive
personality and dependent personality disorders were especially
prevalent (Denys, Tenney, van Megen, de Geus, & Westenberg, 2004).
Additionally, obsessive–compulsive symptoms have been reported in
up to 59.2% of patients with schizophrenia, and up to one-third have
met criteria for clinical OCD (Poyurovsky, Weizman, & Weizman,
2004).
3. Conclusions
The clinical picture for individuals with OCD is complex. The
disorder is marked by a wide heterogeneity of presenting symptoms
arranged into distinct domains requiring speciﬁc therapeutic interventions. Further complicating the implementation of treatment is the
wide array of additional complexities described here, such as
comorbid symptoms, deﬁcits in neuropsychological functioning, not
just right symptoms, and overvalued ideas or scrupulosity. These
complex presentations all have important implications for functioning
and quality of life in individuals with the disorder. However, research
on the effects of treatment on quality of life and functional
improvements is limited. The little empirical research accumulated
to date suggests that some quality of life and functional impairments
may persist, albeit to a lesser degree, following successful treatment of
the condition (Huppert et al., 2009). While it appears that the adverse
functional consequences of the disorder are evident at an early age
(Ledley & Pasupuleti, 2007), it is unclear whether this may be
reversed with successful treatment earlier in the developmental cycle
such as through early intervention or preventative measures with at
risk groups (i.e., in relation to psychiatric disorders generally; Taylor,
Abramowitz, & McKay, 2010). These early ﬁndings are encouraging
and merit replication and further investigation in the treatment of
functional impairments and quality of life among individuals with
various forms of OCD. In addition, presumed prevalence rates have
been on the rise and are still probably underestimated as a result of
embarrassment (e.g., of symptoms such as sexual images or elaborate
blinking rituals) that may keep individuals from seeking treatment.
Although our understanding of OCD has increased signiﬁcantly in
the past two decades, and many theories have been proposed to explain
the nature and etiology of OCD, no single model has fully accounted for
the disorder's complexity (Taylor, McKay, & Abramowitz, 2005).
Accordingly, in future work, researchers and clinicians are encouraged
to view OCD in a multi-dimensional manner, actively collaborating
across such ﬁelds of study as genetics, neuroanatomy, and psychology.
Future research may test multifaceted models examining, for example,
cognitive, behavioral, and family factors that may serve as mediating or
moderating variables between genetic and neurological risk factors and
disorder onset and course. Given the wide heterogeneity of OCD, both in
symptom presentation and complicating factors, additional research is
warranted on which combination of factors are associated with greater
functional impairment. This could shed light on treatment approaches
which are most appropriate for a given subtype of OCD, and lead to
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meaningful treatment decision frameworks. Decision trees for treatment implementation have begun to emerge in other areas within
cognitive behavior therapy (Marder & Chorpita, 2009). Such decision
trees, taking into consideration symptom subtypes, complicating factors
(such as overvalued ideation), comorbidity, and current functional
impairment, would enhance treatment outcome for clients with
obsessive–compulsive disorder.
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